Clinical Trials in an Emerging Brazilian Market

China and India have taken advantage of the need for outsourced clinical trials through contract research organizations, but a new study published by Frost & Sullivan shows that the Brazilian market is emerging as the future of clinical trials.

Daniela Putti, Industry Analyst at Frost & Sullivan mentions

“Higher costs, competition from generics, and lack of productivity from R&D have been challenging pharmaceutical companies worldwide to better manage R&D costs and deadlines as well as improve quality of the whole drug discovery process. To responsibly address these issues, pharmaceutical and biotech companies are seeking for more accessible and efficient clinical trial locations such as emerging countries like Brazil. Here these companies and Contract Research Organizations (CROs) may likely find promising market features and growth opportunities for clinical trials.”

How will this affect current outsourced clinical trials in other countries?